Meta Information
ID:at-home-blood-pressure-monitor
Name:At-Home Blood Pressure Monitor
Schema Version:1.5
Alternate Names
- Home BP Monitor
- Sphygmomanometer
Active Compound
null
Intervention Type
device
Delivery
Route:
none
Scope:
- local
Regulatory Status
- us:otc_medical_device
- eu:medical_device
Indication
Focus:
healthspan
Description:
Monitoring blood pressure, a critical biomarker for cardiovascular health and all-cause mortality risk.
Typical Protocol
- Measure twice daily, once in the morning before medication/caffeine and once in the evening.
- Sit quietly for 5 minutes with feet flat on the floor before measuring.
- Use a validated, properly-sized upper arm cuff for accurate readings.
- Record readings to track trends over time and share with a healthcare provider.
Expected Cost Mean
Low Cost:
30
High Cost:
100
Cost Type:
equipment
Description:
One-time purchase of a validated upper-arm cuff monitor; often covered by insurance.
Summary
An at-home blood pressure monitor is a diagnostic device used to track blood pressure, a primary driver of cardiovascular disease and a key predictor of healthspan. Regular monitoring allows for early detection of hypertension and enables timely lifestyle or medical interventions to maintain optimal vascular health, mitigating a major risk factor for age-related decline.
Purpose
Monitors a key biomarker for cardiovascular health and longevity.
Card Summary
A diagnostic device for tracking blood pressure, a critical biomarker for cardiovascular health and a primary driver of healthspan.
Drug Class
null
Drugs In Class
Empty Array
Impact
Score:
8.5
Justification:
Enables management of blood pressure, a foundational driver of cardiovascular health and mortality.
Evidence
Grade:
A
Score:
10
Justification:
Vast body of evidence links blood pressure control with reduced morbidity and mortality.
Safety
Score:
0.5
Justification:
Non-invasive diagnostic device with minimal physical risk; main risk is inaccurate readings.
Flags
- Improper cuff size or placement can lead to highly inaccurate readings.
- Device calibration should be checked periodically against a clinical-grade monitor.
- Avoid measurement after caffeine, exercise, or during periods of stress for accurate results.
- Focus on trends over time rather than single anomalous readings.
Verdict
A foundational, low-cost tool for managing a critical healthspan biomarker.
Created
2026-05-06T17:21:54.058325Z
Ai Model
Gemini 2.5 Pro (High)